These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of pituitary neoplasms with temozolomide: a review. Syro LV; Ortiz LD; Scheithauer BW; Lloyd R; Lau Q; Gonzalez R; Uribe H; Cusimano M; Kovacs K; Horvath E Cancer; 2011 Feb; 117(3):454-62. PubMed ID: 20845485 [TBL] [Abstract][Full Text] [Related]
4. Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. Raverot G; Sturm N; de Fraipont F; Muller M; Salenave S; Caron P; Chabre O; Chanson P; Cortet-Rudelli C; Assaker R; Dufour H; Gaillard S; François P; Jouanneau E; Passagia JG; Bernier M; Cornélius A; Figarella-Branger D; Trouillas J; Borson-Chazot F; Brue T J Clin Endocrinol Metab; 2010 Oct; 95(10):4592-9. PubMed ID: 20660056 [TBL] [Abstract][Full Text] [Related]
5. The role of temozolomide in the treatment of aggressive pituitary tumors. Liu JK; Patel J; Eloy JA J Clin Neurosci; 2015 Jun; 22(6):923-9. PubMed ID: 25772801 [TBL] [Abstract][Full Text] [Related]
10. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M Eur J Endocrinol; 2010 Dec; 163(6):843-51. PubMed ID: 20870708 [TBL] [Abstract][Full Text] [Related]
11. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas. Losa M; Bogazzi F; Cannavo S; Ceccato F; Curtò L; De Marinis L; Iacovazzo D; Lombardi G; Mantovani G; Mazza E; Minniti G; Nizzoli M; Reni M; Scaroni C J Neurooncol; 2016 Feb; 126(3):519-25. PubMed ID: 26614517 [TBL] [Abstract][Full Text] [Related]
12. Use of temozolomide in aggressive pituitary tumors: case report. Mohammed S; Kovacs K; Mason W; Smyth H; Cusimano MD Neurosurgery; 2009 Apr; 64(4):E773-4; discussion E774. PubMed ID: 19349807 [TBL] [Abstract][Full Text] [Related]
13. Treatment of pituitary neoplasms with temozolomide: A review. Marucci G Cancer; 2011 Sep; 117(17):4101-2; author reply 4102. PubMed ID: 21387270 [No Abstract] [Full Text] [Related]
14. Treatment of aggressive prolactinoma with temozolomide: A case report and review of literature up to date. Chen C; Yin S; Zhang S; Wang M; Hu Y; Zhou P; Jiang S Medicine (Baltimore); 2017 Nov; 96(47):e8733. PubMed ID: 29381964 [TBL] [Abstract][Full Text] [Related]
15. Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review. Almalki MH; Aljoaib NN; Alotaibi MJ; Aldabas BS; Wahedi TS; Ahmad MM; Alshahrani F Hormones (Athens); 2017 Apr; 16(2):139-149. PubMed ID: 28742502 [TBL] [Abstract][Full Text] [Related]
16. Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status. McCormack AI; Wass JA; Grossman AB Eur J Clin Invest; 2011 Oct; 41(10):1133-48. PubMed ID: 21496012 [TBL] [Abstract][Full Text] [Related]
17. How effective is temozolomide for treating pituitary tumours and when should it be used? Halevy C; Whitelaw BC Pituitary; 2017 Apr; 20(2):261-266. PubMed ID: 27581836 [TBL] [Abstract][Full Text] [Related]
18. Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide. Matsuno A; Murakami M; Hoya K; Yamada SM; Miyamoto S; Yamada S; Son JH; Nishido H; Ide F; Nagashima H; Sugaya M; Hirohata T; Mizutani A; Okinaga H; Ishii Y; Tahara S; Teramoto A; Osamura RY Med Mol Morphol; 2014 Mar; 47(1):1-7. PubMed ID: 23955641 [TBL] [Abstract][Full Text] [Related]
19. SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases. Bode H; Seiz M; Lammert A; Brockmann MA; Back W; Hammes HP; Thomé C Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):760-3. PubMed ID: 20496311 [TBL] [Abstract][Full Text] [Related]
20. 65 YEARS OF THE DOUBLE HELIX: Treatment of pituitary tumors with temozolomide: an update. Syro LV; Rotondo F; Ortiz LD; Kovacs K Endocr Relat Cancer; 2018 Aug; 25(8):T159-T169. PubMed ID: 29535142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]